Article & News

Novartis and Eli Lilly have opposed a petition before the Kerala High Court seeking government intervention to make two expensive breast cancer drugs more affordable,

Neph­ro­lo­gists are see­ing patients with kid­ney dys­func­tion who have a his­tory of fre­quent or unsu­per­vised use of paink­illers, with doc­tors warn­ing that repeated use of

A widely reported case has moved xenotransplantation from an experimental possibility towards a serious clinical question.In January 2025, 66-year-old Tim Andrews received a genetically edited

Access to advanced treatment for heart diseases, in tandem with the growth of technologies to support cardiac care, is growing in India and continued investment

Flow Neuroscience, a global company developing new generation of electronic medicine for mental health, announced that FL-100 is now available by prescription across the United

Health disparities in rural areasSome policies and practices have led to health risks and challenges, and related long-term health outcomes, for people living in certain

The Supreme Court on Thursday declined to entertain a plea raising concerns over the government-run nationwide human papillomavirus (HPV) vaccination campaign for adolescent girls to

India aims to pre­vent poten­tially dan­ger­ous drug reac­tions before they reach patients, mov­ing bey­ond largely ret­ro­spect­ive report­ing towards pro­act­ive drug-safety mon­it­or­ing. Under a pro­posed frame­work,

Government plans to replace the Drugs & Cosmetics Act, 1940. This highlights a major regulatory shift. The Draft Drugs, Medical Devices & Cosmetics Bill, 2026

Companies reject the National Pharmaceutical Pricing Authority’s proposal that would place sole legal responsibility for overpricing on manufacturers while shielding retail chemists, hospitals and nursing